PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3321540-3 1987 Oral terbutaline improved morning peak flow (259 v 213 l min-1) and decreased nocturnal inhaler usage (1.3 v 1.9) with no alteration in sleep quality as assessed electroencephalographically. Terbutaline 5-16 CD59 molecule (CD59 blood group) Homo sapiens 57-62 6751838-3 1981 Four increasing doses of terbutaline (0.036-1.23 micrograms kg-1 min-1) were thereafter administered by intravenous infusion, starting 120 min after the tablet intake. Terbutaline 25-36 CD59 molecule (CD59 blood group) Homo sapiens 65-70 17177114-8 2007 For the Bricanyl Turbohaler, increasing FIR from 120 to 600 l min(-1) s(-1) for a constant peak flow rate (PFR) of 60 l min(-1) increased the mean Terbutaline FPF from 18.2% to 45.5%. Terbutaline 147-158 CD59 molecule (CD59 blood group) Homo sapiens 62-68 17177114-8 2007 For the Bricanyl Turbohaler, increasing FIR from 120 to 600 l min(-1) s(-1) for a constant peak flow rate (PFR) of 60 l min(-1) increased the mean Terbutaline FPF from 18.2% to 45.5%. Terbutaline 147-158 CD59 molecule (CD59 blood group) Homo sapiens 120-126 12412676-7 2002 Statistically greater increases in cardiac frequency (2.6 beats x min(-1), p=0.03) were found on terbutaline. Terbutaline 97-108 CD59 molecule (CD59 blood group) Homo sapiens 66-72 10955752-12 2000 Evening peak flows were significantly higher during terbutaline treatment [mean increase 23.1 l min(-1) (95% CI = 18.8, 27.4)]. Terbutaline 52-63 CD59 molecule (CD59 blood group) Homo sapiens 96-102 10955752-15 2000 On ceasing terbutaline treatment there was a fall in mean morning peak flow below the baseline on the following morning of 21.6 l min(-1) (P<0.05 compared to placebo). Terbutaline 11-22 CD59 molecule (CD59 blood group) Homo sapiens 130-136 9643620-8 1998 A similar renal clearance of bambuterol was found during oral administration but that of terbutaline decreased (to about 120 ml min(-1)). Terbutaline 89-100 CD59 molecule (CD59 blood group) Homo sapiens 128-134 8143834-6 1994 Mean lung deposition of terbutaline sulphate inhaled at 57 l.min-1 was 27.0 +/- 7.7%. Terbutaline 24-44 CD59 molecule (CD59 blood group) Homo sapiens 61-66 8112441-6 1993 After treatment with bambuterol, mean morning and evening PEF (SD) were 347 (122) and 365 (121) l.min-1, respectively and 346 (121) and 365 (122) l.min-1, respectively, after treatment with terbutaline. Terbutaline 190-201 CD59 molecule (CD59 blood group) Homo sapiens 148-153 1576070-10 1992 Reducing the inspiratory flow to approximately 34 l min-1 produced slightly reduced side effects and lower plasma terbutaline concentrations. Terbutaline 114-125 CD59 molecule (CD59 blood group) Homo sapiens 52-57